Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: A randomized clinical trial

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Venet, Fabienne ^a,b   Plassais, Jonathan ^a   Textoris, Julien ^a   Cazalis, Marie Angélique ^a   Pachot, Alexandre ^a   Bertin Maghit, Marc ^a   Magnin, Christophe ^a   Rimmelé, Thomas ^a   Monneret, Guillaume ^a,b   Tissot, Sylvie ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; NORADRENALIN; PLACEBO;

ADULT; ARTICLE; BURN; BURN SHOCK; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOTROPIN TEST; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LENGTH OF STAY; LOW DRUG DOSE; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCAR FORMATION; SEPSIS; TREATMENT DURATION; ANTAGONISTS AND INHIBITORS; BURNS; COMPLICATION; METABOLISM; PATHOLOGY; SEPTIC SHOCK; SHOCK;

BURNS; DOUBLE-BLIND METHOD; HUMANS; HYDROCORTISONE; NOREPINEPHRINE; SHOCK; SHOCK, SEPTIC;

EID: 85016510500     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0740-0     Document Type: Article

References (23)

1. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn Wound Infections. Clin Microbiol Rev. 2006;19:403-34.
2. Hettiaratchy S, Dziewulski P. Pathophysiology and types of burns. BMJ. 2004;328:1427-9.
3. Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care Lond Engl. 2009;13:R183.
4. Sanchez R. Initial shock from burns. Physiopathology: therapeutic principles. Pathol Biol (Paris). 2002;50:82-92.
5. Sligl WI, Milner Jr DA, Sundar S, Mphatswe W, Majumdar SR. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis. 2009;49:93-101.
6. Minneci PC, Deans KJ, Eichacker PQ, Natanson C. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect. 2009;15:308-18.
7. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, et al. EFfect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-71.
8. Baxter CR. Problems and complications of burn shock resuscitation. Surg Clin North Am. 1978;58:1313-22.
9. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656-9.
10. Goverman J, Garcia-Toca M, Sheridan RL, Ryan CM. Relative adrenal insufficiency in the adult burn intensive care unit: a report of four cases. Burns J Int Soc Burn Inj. 2008;34:421-4.
11. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937-49.
12. Bock J. Bestimmung des Stichprobenumfangs für biologische Experimente und kontrollierte klinische Studien. München: Oldenbourg Verlag; 1998.
13. Knabl JS, Bauer W, Andel H, Schwendenwein I, Dado PF, Mittlböck M, et al. Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model. Burns J Int Soc Burn Inj. 1999;25:715-21.
14. Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol. 1998;46:589-97.
15. Bellissant E, Annane D. Effect of hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther. 2000;68:293-303.
16. Sherwin RL, Garcia AJ, Bilkovski R. Do low-dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med. 2012;43:7-12.
17. Nácul FE, Jardim A, MacCord F, Penido C, Gomes MV, et al. Hemodynamic instability secondary to adrenal insufficiency in a major burn patient. Burns J Int Soc Burn Inj. 2002;28:270-2.
18. James SE, Ghosh SJ, Montgomerie J, Philp BM, Dziewulski P, et al. Survival of a 75% burn in a patient with longstanding Addison's disease. Burns J Int Soc Burn Inj. 2002;28:391-3.
19. Winter W, Kamolz L, Donner A, Hoerauf K, Blaicher A, Andel H. Hydrocortisone improved haemodynamics and fluid requirement in surviving but not non-surviving of severely burned patients. Burns J Int Soc Burn Inj. 2003;29:717-20.
20. Fuchs PC, Bozkurt A, Johnen D, Smeets R, Groger A, Pallua N. Beneficial effect of corticosteroids in catecholamine-dependent septic burn patients. Burns J Int Soc Burn Inj. 2007;33:306-11.
21. Hoen S, Mazoit J-X, Asehnoune K, Brailly-Tabard S, Benhamou D, Moine P, et al. Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med. 2005;33:2737-43.
22. Walker BR, Williams BC. Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci Lond Engl. 1992;82:597-605.
23. Vinclair M, Broux C, Faure P, Brun J, Genty C, Jacquot C, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med. 2008;34:714-9.